SGAM
BEAT

Smith Group Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Smith Group Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,310
Closed -$111K – 473
2019
Q2 		$111K Hold
2,310
– – ﹤0.01% 230
2019
Q1 		$145K Sell
2,310
-7,410
-76% -$509K ﹤0.01% 239
2018
Q4 		$580K Buy
+9,720
New +$584K 0.02% 186

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Smith Group Asset Management's BEAT Position: Q3 2019 in Review

Smith Group Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 2,310 shares — an estimated $111K sold.

Smith Group Asset Management first reported a position in BEAT in Q4 2018 and held it in 3 quarters. The position peaked at $580K in Q4 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Smith Group Asset Management reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Smith Group Asset Management sold 2,310 BioTelemetry, Inc. shares in Q3 2019, an estimated $111K.
  • Smith Group Asset Management first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 3 quarters.
  • Smith Group Asset Management's BioTelemetry, Inc. position peaked at $580K in Q4 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Smith Group Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.